ClinicalTrials.gov
public full text
Public Domain
Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders
The purpose of this study is to develop biomarkers for central nervous system BH4 concentration in children with autism so they can be easily screened to determine if they may benefit from BH4 supplementation. Kuvan is a synthetic form of BH4. BH4 is an enzyme cofactor that is essential for several critical metabolic functions.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of the Efficacy of an Amino Acid Based Formula in Infants#1007161
- Docosaexahenoic Acid and Gross Motor Milestones in Infants#1153792
- Developmental Effects of Infant Formula Supplemented With LCPUFA#913199
- Chromatin remodeling protein CHD4 regulates axon guidance of spiral ganglion neurons in developing cochlea#1099952
- Colorectal neoplasia-specific amino acid profiles and their diagnostic potential: a systematic review.#483410
Record · ID 873317
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive